Journal home
Advance online publication
Current issue
Archive
Press releases
Free Association (blog)
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Biotechnology
Nature Cell Biology
Nature Medicine
Nature Methods
Nature Reviews Cancer
Nature Reviews Genetics
Nature Reviews Molecular Cell Biology
news@nature.com
Nature Conferences
RNAi Gateway
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Letter
Nature Genetics  34, 297 - 302 (2003)
Published online: 1 June 2003; | doi:10.1038/ng1179

AAV serotype 2 vectors preferentially integrate into active genes in mice

Hiroyuki Nakai1, Eugenio Montini2, 4, Sally Fuess1, Theresa A Storm1, Markus Grompe2, 3 & Mark A Kay1

1  Departments of Pediatrics and Genetics, Stanford University School of Medicine, 300 Pasteur Dr. Rm G305A, Stanford, California 94305, USA.

2  Departments of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon 97201, USA.

3  Department of Pediatrics, Oregon Health & Science University, Portland, Oregon 97201, USA.

4  Present address: Instituto per la cura e la ricerca del Cancro, Candiolo, Torino 10060, Italy.

Correspondence should be addressed to Mark A Kay markay@stanford.edu
Recombinant adeno-associated virus serotype 2 (rAAV2) is a promising vector for gene therapy because it can achieve long-term stable transgene expression in animals and human subjects after direct administration of vectors into various target tissues1. In the liver, although stable transgene expression primarily results from extrachromosomal vector genomes2, a series of experiments has shown that vector genomes integrate into host chromosomes in hepatocytes3, 4, 5 at a low frequency2. Despite the low integration efficiency, recent reports of retroviral insertional mutagenesis in mice6 and two human subjects7, 8 have raised concerns about the potential for rAAV2-mediated insertional mutagenesis. Here we characterize rAAV2-targeted chromosomal integration sites isolated from selected or non-selected hepatocytes in vector-injected mouse livers. We document frequent chromosomal deletions of up to 2 kb at integration sites (14 of 14 integrations, 100%; most of the deletions were <0.3 kb) and preferred integration into genes (21 of 29 integrations, 72%). In addition, all of the targeted genes analyzed (20 of 20 targeted genes, 100%) were expressed in the liver. This is the first report to our knowledge on host chromosomal effects of rAAV2 integration in animals, and it provides insights into the nature of rAAV2 vector integration into chromosomes in quiescent somatic cells in animals and human subjects.


 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

Competing financial interests
Figures & Tables
Supplementary info
See also: News and Views by Russell
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Genetics
ISSN: 1061-4036
EISSN: 1546-1718
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2003 Nature Publishing Group | Privacy policy